Company / Cash per Share
InMed Pharmaceuticals Inc. Cash per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$24.84
FY2025
5-year range
$1.97 / $24.84
FY2022-FY2025
Trend
+1158.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +1158% YoY in FY2025, a notable deviation from the 3-year average annual change of +344%.
Based on SEC 10-K filings.
24.84 in FY2025 with a 3-year CAGR of +2.8%.
Improved from $13.70 to $24.84 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 1158.0% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.84 | +1158.0% |
| FY2024 | $1.97 | -85.6% |
| FY2023 | $13.70 | -40.1% |
| FY2022 | $22.86 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026